Cargando…
Exploring the views of patients' and their family about patient‐initiated follow‐up in head and neck cancer: A mixed methods study
OBJECTIVE: The objective of this work was to explore head and neck cancer (HNC) patients' and their family members' views on acceptability and feasibility of patient‐initiated follow‐up (PIFU), including concerns and anticipated benefits. METHODS: Patients were recruited from UK HNC clinic...
Autores principales: | Lorenc, Ava, Greaves, Colin, Duda, Joan, Brett, Jo, Matheson, Lauren, Fulton‐Lieuw, Tessa, Secher, Denis, Rhodes, Pat, Ozakinci, Gozde, Nankivell, Paul, Mehanna, Hisham, Jepson, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787693/ https://www.ncbi.nlm.nih.gov/pubmed/35789510 http://dx.doi.org/10.1111/ecc.13641 |
Ejemplares similares
-
Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial
por: Lorenc, A., et al.
Publicado: (2022) -
Systematic review of patients’ and healthcare professionals’ views on patient‐initiated follow‐up in treated cancer patients
por: Dretzke, Janine, et al.
Publicado: (2023) -
Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial
por: Jones, David A., et al.
Publicado: (2020) -
Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma
por: Payne, Karl, et al.
Publicado: (2022) -
Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
por: Payne, Karl, et al.
Publicado: (2019)